Persistent N2 disease after induction therapy does not jeopardize early and medium term outcomes of pneumonectomy.

@article{Mansour2008PersistentND,
  title={Persistent N2 disease after induction therapy does not jeopardize early and medium term outcomes of pneumonectomy.},
  author={Ziad Mansour and Evgenia A. Kochetkova and Nicola Santelmo and Xavier Ducrocq and Elisabeth A Quoix and J H Wihlm and Gilbert Massard},
  journal={The Annals of thoracic surgery},
  year={2008},
  volume={86 1},
  pages={228-33}
}
BACKGROUND Operative management of patients with persistent N2 disease after induction therapy is still debated. METHODS One hundred fifty-three consecutive patients underwent pneumonectomy from January 1999 until July 2005; 28 patients (18.3%) had persistent N2 disease after induction therapy (group 1), 32 patients (20.9%) had pathologic stage N0 or N1 after induction therapy (group 2), and 93 patients (60.8%) with pathologic N2 disease underwent immediate surgery (group 3). Short-term end… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Similar Papers

Loading similar papers…